Grant Information
Funding opportunities and grant proposal details for the Beyond the Implant Illness Study.
The Beyond the Implant Illness Study is seeking funding through multiple grant mechanisms to support this critical research. Our multi-pronged approach targets federal, foundation, and industry funding sources that align with our mission to advance the understanding and treatment of Breast Implant Illness.
This comprehensive funding strategy ensures the sustainability and success of the research program while maintaining independence and scientific rigor.
Target Grant Opportunities
Funding Amount
$50,000 per year in direct costs
Project Period
Up to 2 years
Focus for BII Study
The R03 application will focus on the biomarker validation aims (FGF-19 and HLA-DR4), framed as a secondary analysis or feasibility study to comply with the "Clinical Trial Not Allowed" constraint.
Key Deadlines
Earliest application due date: January 16, 2025
Expiration date: January 8, 2028
The PSF Directed Research Grant supports surgeons studying all aspects of breast surgery, including implant safety and reconstruction techniques. This grant is particularly well-suited for the AFG vs. IBA comparison and BEMER PEMF pilot study.
Research Focus Areas
- • Aesthetic and reconstructive breast surgery
- • Breast implant safety research
- • Novel techniques and technologies
- • Patient-reported outcomes
ASERF supports innovative research endeavors within aesthetic surgery that align with their mission to improve the safety and effectiveness of aesthetic procedures. The BII Study's focus on patient outcomes and reconstruction techniques is highly relevant to ASERF's priorities.
Mission Alignment
The Beyond BII Study directly addresses ASERF's core mission by investigating safer alternatives to traditional implants and validating objective diagnostic tools for implant-related complications.
Sample Budget Overview
| Category | Description | Cost (USD) |
|---|---|---|
| Personnel | 0.2 FTE Research Coordinator | $15,000 |
| Supplies | Lab analysis (FGF-19, HLA-DR4) | $10,000 |
| Equipment | BEMER PEMF unit lease/purchase | $5,000 |
| Patient Incentives | Compensation for follow-up visits | $5,000 |
| PROMIS-29 | Annual licensing fee | $2,000 |
| MRI Imaging | Research rate scans (Aim 3) | $13,000 |
| Total Direct Costs | $50,000 | |
Project Management Timeline
Phase 1: Grant Acquisition (Months 1-3)
- • Finalize study protocol
- • Select target grants
- • Draft grant narrative and budget
- • Obtain IRB approval
- • Submit applications
Phase 2: Study Preparation (Months 4-6)
- • Finalize recruitment materials
- • Staff training and certification
- • Secure equipment and supplies
- • Launch patient recruitment campaign
Phase 3: Study Execution (Months 7-24)
- • Patient enrollment and baseline data collection
- • Surgical interventions and follow-up
- • Interim and final data analysis
- • Manuscript preparation and publication
Support This Research
For more information about funding opportunities or to discuss partnership possibilities, please contact us.